Some of the stocks that may grab investor focus today are:
- Moderna Inc MRNA confirmed talks with the government of South Korea to supply the nation with 40 million doses of Covid-19 vaccine. The company also said that its vaccine will be made available to its workers, contractors, and board members under the FDA emergency use authorization. Moderna shares gained 2.7% to close at $114.39 on Tuesday, while declining 0.1% in after-hours trading.
- China Finance Online Co. JRJC reported a Q3 loss of $0.66 per share, versus a year-ago loss of $0.91 per share. Its net revenue climbed to $10.7 million from $8.1 million. China Finance Online shares dipped 25.4% to $8.20 in the after-hours trading session.
- AstraZeneca plc AZN disclosed that its COVID-19 vaccine has received approval in the United Kingdom for emergency use. AstraZeneca shares gained 2.2% to $51.00 in after-hours trading.
Latest Startup Investment Opportunities:
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Choosing the best broker is an important part of being a successful trader or investor
- Shares of Hepion Pharmaceuticals Inc HEPA jumped around 25% on Tuesday after the company disclosed "positive" top line data from the low dose cohort in its Phase 2a 'AMBITION' clinical trial of CRV431. Hepion Pharmaceuticals shares surged 24.5% to $2.59 in after-hours trading.
- Microvision, Inc. MVIS reported a $13 million at-the-market equity facility. Microvision shares dipped 6.7% to $5.90 in the after-hours trading session.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.